Discover
STRO
Sutro Biopharma, Inc.
30.24
2 x 23.66
2 x 37.88
bid
ask
-
2.96
8.92%
2 @ 04:00 PM
29.75 -0.49 (1.62%)
| Ytd | 161.37% | |
| 1y | 344.71% |
29.48
day range
33.39
6.90
52 week range
43.85
| Open | 32.99 | Prev Close | 33.20 | Low | 29.48 | High | 33.39 | Mkt Cap | 501.09M |
| Vol | 473.70K | Avg Vol | 334.10K | EPS | -16.35 | P/E | N/A | Forward P/E | -0.63 |
| Beta | 1.17 | Short Ratio | 2.47 | Inst. Own | 77.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 32.10 | 200-d Avg | 18.89 | 1yr Est | 11.50 |
| Income Statement | |||
| Total Revenue | 14.52M | ||
| Revenues (USD) | 14.52M | ||
| Gross Profit | 14.52M | ||
| Operating Expenses | 44.18M | ||
| Research and Development Expense | 36.55M | ||
| Selling, General and Administrative Expense | 7.58M | ||
| Operating Income | -29.66M | ||
| Interest Expense | 1.01M | ||
| Income Tax Expense | -15.00K | ||
| Net Income | -38.48M | ||
| Net Income Common Stock | -38.48M | ||
| Net Income Common Stock (USD) | -38.48M | ||
| Consolidated Income | -38.48M | ||
| Earnings per Basic Share | -2.94 | ||
| Earnings per Basic Share (USD) | -2.94 | ||
| Earnings per Diluted Share | -2.94 | ||
| Earning Before Interest & Taxes (EBIT) | -37.49M | ||
| Earning Before Interest & Taxes (USD) | -37.49M | ||
| Weighted Average Shares | 13.08M | ||
| Weighted Average Shares Diluted | 13.08M | ||
| Balance Sheet | |||
| Cash and Equivalents | 74.54M | ||
| Cash and Equivalents (USD) | 74.54M | ||
| Investments | 128.88M | ||
| Investments Current | 128.88M | ||
| Trade and Non-Trade Receivables | 12.48M | ||
| Current Assets | 220.97M | ||
| Property, Plant & Equipment Net | 19.07M | ||
| Total Assets | 241.99M | ||
| Debt Current | 7.60M | ||
| Total Debt | 13.63M | ||
| Current Liabilities | 70.81M | ||
| Debt Non-Current | 6.03M | ||
| Total Liabilities | 308.88M | ||
| Accumulated Retained Earnings (Deficit) | -1.02B | ||
| Accumulated Other Comprehensive Income | -101.00K | ||
| Shareholders Equity | -66.89M | ||
| Shareholders Equity (USD) | -66.89M | ||
| Assets Non-Current | 21.02M | ||
| Total Debt (USD) | 13.63M | ||
| Deferred Revenue | 10.63M | ||
| Liabilities Non-Current | 238.06M | ||
| Trade and Non-Trade Payables | 5.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.47M | ||
| Net Cash Flow from Financing | 103.08M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 15.55M | ||
| Capital Expenditure | -11.00K | ||
| Issuance (Purchase) of Equity Shares | 103.24M | ||
| Net Cash Flow from Investing | -45.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -45.25M | ||
| Net Cash Flow from Operations | -42.26M | ||
| Share Based Compensation | 1.56M | ||